NCT05450770View on ClinicalTrials.gov

Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions

HIV InfectionsYellow Fever

Interventions

BIOLOGICAL

Yellow fever vaccination (STAMARIL)

Yellow fever vaccination (STAMARIL) for HIV positive and negative subjects

All Listed Sponsors

collaborator

Saint-Louis Hospital, Paris, France

OTHER

collaborator

Bichat Hospital

OTHER

collaborator

Hôpital Cochin

OTHER

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT05450770 - Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination | Biotech Hunter | Biotech Hunter